Home > Investor Relations

Investor Relations

Quick Links

Offer Documents

DRHP/RHP
Second Corrigendum on Niva Bupa Health Insurance Company Limited-DRHP
Corrigendum on Niva Bupa Health Insurance Company Limited-DRHP
Details of outstanding dues to Material Creditors
FY2024 IFRS financials
Industry Report
Reconciliation from IGAAP to IFRS
Summary of qualitative differences between IGAAP and IFRS
Niva Bupa Health Insurance Co Ltd DRHP
Niva Bupa Health Insurance Co Ltd RHP
Equity & Profit Recon Jun2024
June 24 IFRS Signed FS and AR 1
Abridged Prospectus
FINANCIAL EXPRESS-ENGLISH-Price Band Ad
FINANCIAL EXPRESS-MUMBAI-ENGLISH-RHP STAT AD
JANSATTA-DELHI-HINDI-PRICE BAND AD
JANSATTA-DELHI-HINDI-RHP STAT AD
Material Contracts
Amendment to Offer Agreement-23 Oct 2024
Syndicate Agreement - 30 Oct 2024
Share Escrow Agreement -30 Oct 2024
Cash Escrow and Sponsor Bank Agreement
Offer Agreement-29 June 2024
Registrar Agreement
Material Documents
Amendment and Waiver Agreement to the Investment Agreement
Annual Report_2021-22
Annual Report_2022-23
Annual Report _2023-24
Appointment letter_Mr. Krishnan
Article of Association
CAM Consent Letter
Certificate of Commencement of business
Certificate of Incorporation_05 Sept 2008
CoI_Pursuant to Name Change_13 July 2009
COI-Pursuant to Name Change_05 July 2021
Consent letter Auditor
Consent letter from Compliance officer and CS
Consent Letter_HDFC Securities_Syndicate Member
Consent Letter_Kotak Securities_Syndicate Member
Consent OFS_Bupa SIngapore
Consent OFS_Fettle Tone
CTC_Audit Committee
CTC_consent letter_signed
CTC_DRHP
CTC_RHP_signed
CTC_SR_Raising of capital
CTC-Board_IPO_May 10, 2024
Director Consents
DRHP_CTC
Due Diligence Certificate
ESOP Scheme 2020
ESOP Scheme_2024
Examination Report
Fettle Tone_OFS Niva Bupa
Industry Report Redseer
In-principle listing approval_BSE NSE
IRDAI Approval- 17 May 2024
IRDAI Registration Certificate
KPI Cert. Auditors
Memorandum of Association
SEBI final observation letter
SPA Amendment Agreement - A91-FT
Special tax Benefit cert.
St. Auditors joint consent
Termination cum Amendment Agreement to the SHA
Trade Mark Agreement_BUPA
Tripatriate Agreement_ CDSL
Tripatriate Agreement_NSDL

Financial Disclosures

Un-audited Financial Results quarter ended June 30, 2022
Audited Financial Results for the quarter & year ended March 31, 2022
Unaudited Financial Results quarter ended December 31, 2021
Annual Financials -FY 20-21
Annual Financials -FY 19-20
Annual Financials -FY 18-19

Other Disclosures as per Debt listed Company

Notice of 16th Annual General Meeting
Intimation of AGM- August 6, 2024
Disclosure Under Regulation 51
Credit Rating
Disclosure under Regulation 55 & Regulation 51
Notice of Board Meeting - May 10, 2024
Outcome of Board Meeting- May 10, 2024
Audited Financial Results for the quarter & year ended March 31, 2024
Intimation of EGM - May 10, 2024
Proceedings of EGM - May 10,2024
Newspaper publication of financial results for the period ended March 31, 2024
Disclosure under Regulation 51
Proceedings of EGM - June 21,2024
Credit Rating – December 2023
Disclosure under Regulation 51
Reporting under Chapter XIV of SEBI Operational Circular
Certificate under Regulation 61(4) & 40(9) for the financial year ended March 31, 2024
Initial Disclosure for the financial year ended March 31, 2024
Compliance Certificate for the financial year ended March 31, 2024
Investor Grievance Report for the quarter ended March 31, 2024
Details of the RTA under Regulation 7(1) for the quarter ended March 31, 2024
Details of the CO under Regulation 6(1) for the quarter ended March 31, 2024
Reporting under SEBI Operational Circular for the half year ended March 31, 2024
Disclosure under Regulation 57(1)
Intimation of Record Date
Newspaper publication of financial results for the quarter and nine months period ended December 31, 2023
Un-audited Financial Results for quarter and nine months ended December 31, 2023
Outcome of Board Meeting- February 13, 2024
Notice of Board Meeting -February13, 2024
Details of the RTA under Regulation 7(1) for the quarter ended December 31, 2023
Investor Grievance Report for the quarter ended December 31, 2023
Details of the CO under Regulation 6(1) for the quarter ended December 31, 2023
Proceedings of EGM - January 3, 2023
Disclosure under Regulation 51
Intimation of EGM - January 3, 2023
Notice of Board Meeting - January 3, 2023
Proceedings of EGM - December 13, 2023
Disclosure under Regulation 51
Intimation of EGM - December 13, 2023
Notice of Board Meeting - December 13, 2023
Disclosure under Regulation 57(1)
Newspaper publication of financial results for the quarter and half year ended September 30, 2023
Proceedings of EGM - November 02, 2023
Un-audited Financial Results for quarter and half year ended September 30, 2023
Outcome of Board Meeting- November 02, 2023
Intimation of EGM - November 02, 2023
Notice of Board Meeting - November 02, 2023
Intimation of Record Date
Disclosure under Regulation 51
Disclosure under Regulation 51
Reporting under SEBI Operational Circular for the half year ended September 30, 2023
Details of the RTA under Regulation 7(1) for the quarter ended September 30, 2023
Investor Grievance Report for the quarter ended September 30, 2023
Details of the CO under Regulation 6(1) for the quarter ended September 30, 2023
Proceedings of EGM - September 27, 2023
Disclosure under Regulation 51
Intimation of EGM - September 27, 2023
Notice of Board Meeting - September 27, 2023
Notice of Board Meeting - September 27, 2023
Compliance under Regulation 57(4) for the quarter ended December 31, 2023
Outcome of Board Meeting- September 18, 2023
Notice of Board Meeting - September 18, 2023
Newspaper publication of financial results for the period ended June 30, 2023
Un-audited Financial Results for quarter ended June 30, 2023
Outcome of Board Meeting-August 03, 2023
Notice of Board Meeting - August 03, 2023
Details of the RTA under Regulation 7(1) for the quarter ended June 30, 2023
Investor Grievance Report for the quarter ended June 30, 2023
Details of the CO under Regulation 6(1) for the quarter ended June 30, 2023
Compliance under Regulation 57(5) for the quarter ended June 30, 2023
Proceedings of 15th AGM- June 28, 2023
Compliance under Regulation 57(4) for the quarter ended September 30, 2023
Submission of Annual Report for the financial year ended March 31, 2023
Intimation of AGM- June 28, 2023
Notice of 15th Annual General Meeting
Newspaper publication of financial results for the period ended March 31, 2023
Audited Financial Results for the quarter & year ended March 31, 2023
Outcome of Board meeting –May 4, 2023
Notice of Board meeting – May 04, 2023
Reporting under Chapter XIV of SEBI Operational Circular
Initial Disclosure for the financial year ended March 31, 2023
Compliance under Regulation 57(5) for the quarter ended March 31, 2023
Certificate under Regulation 61(4) & 40(9) for the financial year ended March 31, 2023
Investor Grievance Report for the quarter ended March 31, 2023
Reporting under SEBI Operational Circular for the half year ended March 31, 2023
Details of the RTA under Regulation 7(1) for the quarter ended March 31, 2023
Details of the CO under Regulation 6(1) for the quarter ended March 31, 2023
Compliance under Regulation 57(5) for the quarter ended December 31, 2022
Compliance under Regulation 57(4) for the quarter ended March 31, 2023
Notice of Board Meeting - March 31, 2023
Disclosure under Regulation 57(1)
Intimation under Regulation 51(2)
Disclosure under Regulation 57(1)
Newspaper publication of financial results for the quarter and half year ended September 30, 2022
Disclosure under Regulation 54
Disclosure under Regulation 51(2) - November 3, 2022
Proceedings of the EGM - November 3, 2022
Intimation of EGM-November 3, 2022
Un-audited Financial Results for quarter and half year ended September 30, 2022
Outcome of Board Meeting-November 3, 2022
Notice of Board meeting – November 3, 2022
Investor Grievance Report for the quarter ended September 30, 2022
Intimation of Record date
Newspaper publication of financial results for the quarter and nine months' period ended December 31, 2022
Un-audited Financial Results for quarter ended December 31, 2022
Outcome of Board Meeting-February 9, 2023
Notice of Board Meeting- February 09, 2023
Investor Grievance Report for the quarter ended December 31, 2022
Details of the RTA under Regulation 7(1) for the quarter ended December 31, 2022
Disclosure under Regulation 55
Details of the CO under Regulation 6(1) for the quarter ended December 31, 2022
Details of CO & RTA for the quarter ended September 30, 2022
Compliance under Regulation 57(5) for the quarter ended September 30, 2022
Reporting under SEBI Operational Circular for the half year ended September 30, 2022
Notice of Board meeting - October 7, 2022
Compliance under Regulation 57(4) for the quarter ended December 31, 2022
Newspaper publication of financial results for the quarter ended June 30, 2022
Outcome of Board Meeting –August 10, 2022
Notice of Board meeting –August 10, 2022
Details of CO & RTA for the quarter ended June 30, 2022
Investor Grievance Report for the quarter ended June 30, 2022
Compliance under Regulation 57(5) for the quarter ended June 30 2022
Compliance under Regulation 57(4) for the quarter ended September 2022
Proceedings of the 14th AGM-June 9, 2022
Intimation of AGM-June 9, 2022
Submission of Annual Report for the financial year ended March 31, 2022
Statement of utilisation of proceeds as at March 31, 2022
Newspaper publication of financial results for the period ended March 31, 2022
Outcome of Board meeting –May 5, 2022
Security Cover as at March 31, 2022
Reporting under Chapter XIV of SEBI Operational Circular
Notice of Board meeting –May 5, 2022
Details of CO & RTA for the quarter ended March 31, 2022
Compliance Certificate for the financial year ended March 31, 2022
Certificate under Regulation 61(4) & 40(9) for the financial year ended March 31, 2022
Initial Disclosure for the financial year ended March 31, 2022
Investor Grievance Report for the quarter ended March 31, 2022
Reporting under SEBI Operational Circular for the half year ended March 31, 2022
Compliance under Regulation 57(5) for the quarter ended March 31 2022
Outcome of Board meeting –March 8, 2022
Notice of Board meeting –March 8, 2022
Details of CO & RTA for the quarter ended December 31, 2021
Newspaper publication of financial results for the quarter ended December 31, 2021
Statement of utilisation of proceeds as at December 31, 2021
Investor Grievance Report for the quarter ended December 31, 2021
Notice of Board meeting for the quarter ended December 31, 2021
Obligations for payment for the quarter ended December 31, 2021

Policies

Nomination and Remuneration Policy
Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information
Policy for Inquiry in case of Leak or Suspected Leak of Unpublished Price Sensitive Information
Policy on Familiarisation Programme for the Independent Directors
Board Diversity Policy
Policy on the Evaluation of the Performance of the Board of Directors.
Policy on Succession Planning for Appointment of Directors, Key Managerial Personnel and Senior Management
Risk Management Policy
Corporate Social Responsibilities Policy
Authorised person to determine materiality of events and information
Code of conduct of Board of Directors and Senior Management
Policy for determination material subsidiary
Policy for determination of materiality threshold for disclosure of events or information
Dividend Distribution Policy
Related party Transactions Policy

Composition of Board Committees

Composition of Board Committees

Annual Returns

Credit Rating

CREDIT RATING FOR SUBORDINATED DEBT :

Rating Agency Rating Rating Date
CARE Ratings Ltd. CARE A; Stable November 2, 2021
CARE Ratings Ltd. CARE A; Stable March 1, 2022
CARE Ratings Ltd. CARE A; Stable December 30, 2022
CARE Ratings Ltd. CARE A+; Stable December 27, 2023
CARE Ratings Ltd. CARE AA; Stable June 27, 2024
INVESTOR GRIEVANCE

 All investor queries/complaints/grievances directed to:

NameMr. Rajat Sharma
DesignationCompany Secretary
Contact details0124-6354900
Email IDInvestor@nivabupa.com

DEBENTURE TRUSTEE:

AXIS TRUSTEE SERVICES LIMITED
SEBI Registration Number: IND000000494
Registered Office: Axis House, Bombay Dyeing Mills Compound, Pandurang Budhkar Marg, Worli, Mumbai – 400025.
Corporate Office: The Ruby, 2nd Floor, SW, 29 Senapati Bapat Marg, Dadar West, Mumbai – 400028
Telephone: (022) 6230 0451 | Facsimile: +91-22-62300700
E-mail: debenturetrustee@axistrustee.in